These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22117909)

  • 1. Comparison of outcomes in patients with abandoned versus extracted implantable cardioverter defibrillator leads.
    Amelot M; Foucault A; Scanu P; Gomes S; Champ-Rigot L; Pellissier A; Milliez P
    Arch Cardiovasc Dis; 2011 Nov; 104(11):572-7. PubMed ID: 22117909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?
    Glikson M; Suleiman M; Luria DM; Martin ML; Hodge DO; Shen WK; Bradley DJ; Munger TM; Rea RF; Hayes DL; Hammill SC; Friedman PA
    Heart Rhythm; 2009 Jan; 6(1):65-8. PubMed ID: 19121802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-centre experience concerning the safety of Sprint Fidelis defibrillator lead extraction at the time of pulse generator replacement or in case of evidence of lead failure.
    Da Costa A; Da Cruz C; Romeyer-Bouchard C; Abdellaoui L; Nadrouss A; Bisch L; Chometon F; Afif Z; Gate-Martinet A; Combier M; Isaaz K
    Arch Cardiovasc Dis; 2012 Apr; 105(4):203-10. PubMed ID: 22633294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explantation of implantable defibrillator leads using open heart surgery or percutaneous techniques.
    Camboni D; Wollmann CG; Löher A; Gradaus R; Scheld HH; Schmid C
    Ann Thorac Surg; 2008 Jan; 85(1):50-5. PubMed ID: 18154777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should all dysfunctional high-voltage leads be extracted? Results of a single-centre long-term registry.
    Bode F; Himmel F; Reppel M; Mortensen K; Schunkert H; Wiegand UK
    Europace; 2012 Dec; 14(12):1764-70. PubMed ID: 22753865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the transvenous extraction of cardioverter-defibrillator leads more hazardous than that of pacemaker leads?
    Małecka B; Kutarski A; Grabowski M
    Kardiol Pol; 2010 Aug; 68(8):884-90. PubMed ID: 20730717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of recalled implantable cardioverter-defibrillator leads at generator replacement: a decision analysis model for Fidelis leads.
    Burri H; Combescure C
    Europace; 2014 Aug; 16(8):1210-7. PubMed ID: 24469434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of failure of transvenous implantable cardioverter-defibrillator leads.
    Borleffs CJ; van Erven L; van Bommel RJ; van der Velde ET; van der Wall EE; Bax JJ; Rosendaal FR; Schalij MJ
    Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):411-6. PubMed ID: 19808497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators.
    Steven D; Roberts-Thomson KC; Inada K; Seiler J; Koplan BA; Tedrow UB; Sweeney MO; Epstein LE; Stevenson WG
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1115-9. PubMed ID: 21545364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
    Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
    J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure-free survival of the Durata defibrillator lead.
    Liu J; Patel D; Rattan R; Brumberg G; Saini A; Vaghasia N; Bazaz R; Adelstein E; Jain S; Saba S
    Europace; 2013 Jul; 15(7):1002-6. PubMed ID: 23376976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.